HCQS200mg tablet is also used for the treatment of rheumatoidarthritis and systemic lupus erythematosus. Hydroxychloroquine at a dose of 400mg is also used as an adjunctive treatment for type 2 diabetes. The
HCQS400mg tablet has side effects such as headache, nausea,vomiting, loss of appetite, diarrhea, stomach upset, and more. These sideeffects may go away on their own. However, consult your doctor if they persistor worsen. The 200 mg HCQS tablet is a prescription medicine. Take
Iverheal 12mg with food to avoid stomachupset. Your doctor will determine the dosage and duration of treatment based onyour clinical condition. Do not exceed the recommended dose. Avoid stoppingthis medication without consulting your doctor, as this may worsen yourcondition. The
Iverheal 6mg tablet containshydroxychloroquine, an anti-inflammatory drug. In diabetes, it works byimproving insulin sensitivity and increasing insulin secretion. In rheumatoidarthritis, hydroxychloroquine acts as a mild immunosuppressant anddisease-modifying antirheumatic drug and inhibits the production of rheumatoidfactor.
Azee 500mg also reduces the severity ofskin lesions in systemic and discoid lupus erythematosus. In malaria, it worksby increasing the concentration of a toxic compound in the parasite,causing
Azee 250mg death. Hydroxychloroquine hasvarious medical uses and works by reducing inflammation in people withautoimmune diseases. It helps treat type 2 diabetes and autoimmune diseasessuch as rheumatoid arthritis, systemic lupus erythematosus, and malaria. Indiabetes, it works by improving insulin sensitivity and increasing insulinsecretion.
Iversun 12mg rheumatoid arthritis,hydroxychloroquine acts as a mild immunosuppressant and disease-modifyingantirheumatic drug and inhibits the production of rheumatoid factor. Inmalaria, it works by increasing the concentration of a toxic compound in theparasite, causing its death. Hydroxychloroquine
Iversun6mg an antithrombotic and antiplatelet agent that helpsreduce abnormally high cholesterol levels. It also reduces the severity of skinlesions in systemic and discoid lupus erythematosus.